Patents by Inventor Lin LUIS

Lin LUIS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS TARGETING S100A10 FOR THE TREATMENT AND DIAGNOSIS OF LIVER CANCER
    Publication number: 20240094211
    Abstract: Compositions and methods for early diagnosis, risk stratification, and effective management and treatment of patients with hepatocellular carcinoma are provided. The compositions and methods selectively target S100A10, for effective detection of S100A10 in a subject, for example, from plasma samples or from tissue biopsy, and for effective inhibiting and/or reducing the activities and/or quantities of S100A10 in vitro and/or in vivo. Methods for selecting patients who would be amenable for the disclosed therapies and for treating such patients are also described.
    Type: Application
    Filed: July 13, 2023
    Publication date: March 21, 2024
    Inventors: Irene Oi Lin Lui Ng, Xia Wang
  • USE OF LANCL1 AND ANTIBODIES THEREOF AS A DIAGNOSTIC AND THERAPEUTIC TARGET FOR THE MANAGEMENT AND TREATMENT OF CANCER
    Publication number: 20230348622
    Abstract: The subject invention pertains to antibodies that target LANCL1. The anti-LANCL1 antibodies can be used in methods of treating cancer, including hepatocellular carcinoma. The anti-LANCL1 antibody can be used as a therapeutic regimen for treatment or as part of a combination treatment. Further, the anti-LANCL1 antibodies may also be useful for targeting the tumor initiating cells.
    Type: Application
    Filed: March 24, 2023
    Publication date: November 2, 2023
    Inventors: Irene Oi Lin Lui Ng, Yu Man Tsui
  • ANTI-PCSK9 ANTIBODIES, FORMULATIONS, DOSING, AND METHODS OF USE
    Publication number: 20160355606
    Abstract: The invention provides anti-PCSK9 antibodies, formulations, dosing regimens, and methods of using the same.
    Type: Application
    Filed: December 28, 2015
    Publication date: December 8, 2016
    Inventors: Yan Wu, Cecilia Pui Chi Chiu, Daniel K. Kirchhofer, Andrew Peterson, Ganesh A. Kolumam, Monica Kong Beltran, Paul Moran, Wei Li, Xanthe Lam, Lin Luis, Ada Hui, Whittemore Tingley, John Douglas Davis, Nageshwar R. Budha
  • Anti-PCSK9 antibodies, formulations, dosing, and methods of use
    Patent number: 9266961
    Abstract: The invention provides anti-PCSK9 antibodies, formulations, dosing regimens, and methods of using the same.
    Type: Grant
    Filed: June 14, 2013
    Date of Patent: February 23, 2016
    Assignee: Genentech, Inc.
    Inventors: Yan Wu, Cecilia Pui Chi Chiu, Daniel K. Kirchhofer, Andrew Peterson, Ganesh A. Kolumam, Monica Kong Beltran, Paul Moran, Wei Li, Xanthe M. Lam, Lin Luis, Ada Hui
  • ANTI-PCSK9 ANTIBODIES, FORMULATIONS, DOSING, AND METHODS OF USE
    Publication number: 20130344085
    Abstract: The invention provides anti-PCSK9 antibodies, formulations, dosing regimens, and methods of using the same.
    Type: Application
    Filed: June 14, 2013
    Publication date: December 26, 2013
    Inventors: Yan WU, Cecilia Pui Chi CHIU, Daniel K. KIRCHHOFER, Andrew PETERSON, Ganesh A. KOLUMAM, Monica Kong BELTRAN, Paul MORAN, Wei LI, Xanthe LAM, Lin LUIS, Ada HUI, Whittemore TINGLEY, John Douglas DAVIS, Nageshwar R. BUDHA